folates has prompted research into the metabolism of folates in malignant tumours. However, most studies have used folic acid as a tracer, though this compound is not naturally occurring, and is only assimilated by an unusual reaction of DHFR (Gready, 1979) . We report the metabolism of 5-methyltetrahydrofolate (5MeTHF) a naturally occurring reduced folate, in rats bearing the Walker 256 carcinosarcoma. This tumour is of special interest as, in cell culture, it has been claimed to display methionine auxotrophy, while normal cells are able to survive substitution of methionine by homocysteine (Halpern et al., 1974) . It has been suggested that other cell lines with similar properties are deficient in 5MeTHF, requiring methionine synthetase (Ashe et al., 1974) .
This effect, however, is not found in all tumour cQll lines (Magnum et al., 1969; Tisdale, 1979) showing that methionine auxotrophy is a poor indicator of malignancy (Kreis & Goodenow, 1978) . With Walker 256, Hoffman & Erbe (1976) showed that although the line has a methionine requirement, both FA and 5MeTHF are equally effective in stimulating the folate-depleted cell to divide. The cells are also able to take up 5MeTHF normally and use it for methionine synthesis at a rate similar to or above normal cells (Hoffman & Erbe, 1976 (4) implanted ( weight. Normal males of the same strain were used as controls.
Radiotracers were dissolved in phosphate buffer (pH 7 0, 50 mM) containing 2% (w/v) sodium ascorbate. The animals, in groups of 4-6, were dosed orally with up to 2 puCi 14C or 5 pCi 3H of the compound under study. The animals were then placed in metabolism cages (Jencons, Herts) which enabled the collection of expired CO2 (trapped in 100 ml of 2M NaOH) urine and faeces. Collecting flasks for urine were protected from light and contained 5 ml sodium phosphate buffer (pH 7-0, 50 mM) plus 100 mg sodium ascorbate. Typically, urine was collected from 0-6, 6-24, 24-48 and 48-72 h after administration, with faeces and CO2 collected daily. Throughout this period the animals had access to food and water ad libitum. Three days from the start of the experiment the animals were killed and the tumour and various organs excised.
Urine samples and column effluents were counted as described in Connor et al., (1979) . Faeces and tissues were freeze-dried, and 100mg samples used to determine total radioactivity as described in Barford et al. (1978) . Sephadex G15 gel filtration, DEAEcellulose chromatography (Barford, et al., 1977) and paper chromatography (Connor et al., 1979) were performed as described previously.
The distribution and excretion of 14C activity following an oral dose of 5[14C]-MeTHF (80 jug/kg) are given in Table I . The tumour-bearing animals showed greater production of 14CO2, greater 14C retention in the liver and less retention in muscle than normal animals. Chromatographic analysis of the urine samples showed the presence of 5MeTHF and the non-folate fraction (NFF; methionine + creatine) as described in Kennelly et al. 1979) . No qualitative difference was observed between the 2 groups of animals, but the tumour-bearing animals showed an absolutely and proportionally greater excretion of NFF than normals and less 5-MeTHF excretion (Table II) .
Normal and tumour-bearing animals were dosed orally with [2-14C] + [3',5',7,9-3H] 5MeTHF at 8 and 6 ,ug/kg respectively. The distribution of radioactivity recovered is given in Table III . Notably, excretion of radioactivity in urine and faeces was less in tumour-bearing rats than normals (P < 0.001 for both 14C and 3H). The excreted urinary metabolites were qualitatively similar in the 2 groups; scission products, 10CHOFA, 5-MeTHF and an unidentified dual-labelled compound ("folate X" as reported in Saleh et al., 1981) (Table IV) . However, some 6-5 14-1 14-9 4-2 3-8 24-4 32-9 11-7 11-3 15-9 19-7 0 4 4-1 differences were seen in the proportion of the radioactivity excreted as the different folates. The 3H-labelled scission products were separated by Sephadex G15 into 2 fractions, identified by paper chromatography (Connor et al., 1979) as p-acetamidobenzoylglutamate and p-acetamidobenzoate. Less of the dose was catabolized to scission products by the tumour-bearing animals, despite the retention of more radioactivity in the tissues. The presence of an implanted Walker 256 carcinosarcoma imposes changes on the whole body metabolism of 5MeTHF in the rat, both of the methyl group and the tetrahydrofolate moiety. There is more rapid demethylation and a diversion of methyl groups from muscle. This is accompanied by retention of radioactivity in the tumour, increased retention in the liver and increased production of C02 (Table I) . As this particular tumour displays an in vitro methionine requirement, the diversion of methyl groups from muscle may be due to the tumour's demand for methionine, and its metabolism to C02.
Following a dose of mixed label [2-14C] + [3',5',7,9-3H]5-MeTHF, markedly less radioactivity was excreted in the urine and faeces of the tumour-bearing animals, indicating that the presence of the tumour increased the demand for folate. Also folate scission was reduced, both absolutely and as a proportion of the body burden of folate polyglutamates in the tumour-bearing animals. Similar observations have been made using radioactive folic acid as the tracer (Saleh et al., 1981) ; these data confirm the phenomenon with a naturally occurring reduced folate. The fact that similar results are obtained with folic acid and 5MeTHF also suggests that the methionine auxotrophy of the Walker 256 carcinosarcoma is not due to inability to demethylate 5MeTHF.
